142 related articles for article (PubMed ID: 35615381)
1. Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts.
Liang S; Fang K; Li S; Liu D; Yi Q
Front Genet; 2022; 13():872441. PubMed ID: 35615381
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer.
Zhou L; Xu G; Huang F; Chen W; Zhang J; Tang Y
BMC Med Genomics; 2023 Apr; 16(1):88. PubMed ID: 37118734
[TBL] [Abstract][Full Text] [Related]
3. Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
Zhang LH; Li LQ; Zhan YH; Zhu ZW; Zhang XP
Front Mol Biosci; 2021; 8():607090. PubMed ID: 33937319
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
[TBL] [Abstract][Full Text] [Related]
5. Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts.
Ren X; Chen X; Zhang X; Jiang S; Zhang T; Li G; Lu Z; Zhang D; Wang S; Qin C
Front Immunol; 2021; 12():686809. PubMed ID: 34777331
[TBL] [Abstract][Full Text] [Related]
6. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
7. An immune-related gene signature for the prognosis of human bladder cancer based on WGCNA.
Cheng J; Zhang S; Fan A; Li Y; Xu P; Huang J; He M; Wang H
Comput Biol Med; 2022 Dec; 151(Pt A):106186. PubMed ID: 36335813
[TBL] [Abstract][Full Text] [Related]
8. Exploration of the immune microenvironment of breast cancer in large population cohorts.
Deng Y; Wang J; Hu Z; Cai Y; Xu Y; Xu K
Front Endocrinol (Lausanne); 2022; 13():955630. PubMed ID: 36046784
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes.
Zhao H; Chen Z; Fang Y; Su M; Xu Y; Wang Z; Gyamfi MA; Zhao J
J Immunol Res; 2022; 2022():1793005. PubMed ID: 35450397
[TBL] [Abstract][Full Text] [Related]
11. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
Fu Y; Sun S; Bi J; Kong C; Yin L
BMC Cancer; 2021 Jul; 21(1):810. PubMed ID: 34266411
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.
Zhu K; Deng W; Deng H; Liu X; Wang G; Fu B
PPAR Res; 2021; 2021():7056506. PubMed ID: 35027921
[TBL] [Abstract][Full Text] [Related]
13. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X
Front Immunol; 2021; 12():725223. PubMed ID: 34484235
[TBL] [Abstract][Full Text] [Related]
14. Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
Zhang L; Li L; Zhan Y; Wang J; Zhu Z; Zhang X
Front Oncol; 2020; 10():542140. PubMed ID: 33552945
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
17. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
18. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
Front Genet; 2021; 12():551605. PubMed ID: 33732281
[No Abstract] [Full Text] [Related]
19. The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia.
Xiao Y; Yang J; Yang M; Len J; Yu Y
Front Oncol; 2022; 12():916850. PubMed ID: 36479065
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
Chen X; Jin Y; Gong L; He D; Cheng Y; Xiao M; Zhu Y; Wang Z; Cao K
Front Genet; 2020; 11():607. PubMed ID: 32655621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
